Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-10

Clinical Trial Update: F 18 T807 Tau PET Imaging in Dominantly Inherited Alzheimer's Network (DIAN Project)

View source ↗

Summary

Clinical trial update on the F18 T807 tau PET imaging tracer (flortaucipir) used in the Dominantly Inherited Alzheimer Network, with enrollment by invitation on…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • F18 T807 (flortaucipir)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Alzheimer Disease | Status: ENROLLING_BY_INVITATION